Brennan Daniel J.'s Form 4 filing
Boston Scientific Corp (BSX) · filed Jan 3, 2025
- Accession no.
- 0001225208-25-000201
- Filed
- Jan 3, 2025
- Trade date
- Jan 1-3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $870.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brennan Daniel J.CIK 0001595612 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | Common Stock | MOption exerciseAcquired | +14,901 | $0.00 | $0 | 238,822 | Direct | |
| Jan 1, 2025 | Common Stock | FTax withholdingDisposed | −5,212 | $89.32 | −$465,535.84 | 233,610 | Direct | |
| Jan 3, 2025 | Common Stock | SSaleDisposed | −9,689 | $89.86F3 | −$870,653.54 | 223,921 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | Common Stock | MOption exerciseDisposed | −14,901 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $89.52 to $90.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.